Share on StockTwits

Illumina (NASDAQ:ILMN) SVP Christian O. Henry sold 10,000 shares of the company’s stock in a transaction dated Wednesday, September 3rd. The shares were sold at an average price of $180.59, for a total value of $1,805,900.00. Following the transaction, the senior vice president now directly owns 28,630 shares in the company, valued at approximately $5,170,292. The transaction was disclosed in a filing with the SEC, which is available at this link.

A number of research firms have recently commented on ILMN. Analysts at Wedbush upgraded shares of Illumina from a “neutral” rating to an “outperform” rating in a research note on Wednesday, August 20th. They now have a $200.00 price target on the stock, up previously from $165.00. Separately, analysts at Stifel Nicolaus initiated coverage on shares of Illumina in a research note on Monday, August 11th. They set a “buy” rating and a $200.00 price target on the stock. Finally, analysts at Goldman Sachs raised their price target on shares of Illumina from $184.00 to $187.00 in a research note on Tuesday, August 5th. Four investment analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the stock. Illumina currently has an average rating of “Buy” and a consensus price target of $178.92.

Illumina (NASDAQ:ILMN) traded down 0.33% during mid-day trading on Thursday, hitting $177.20. 861,862 shares of the company’s stock traded hands. Illumina has a 1-year low of $72.77 and a 1-year high of $185.00. The stock’s 50-day moving average is $170.3 and its 200-day moving average is $161.8. The company has a market cap of $24.702 billion and a P/E ratio of 118.76.

Illumina (NASDAQ:ILMN) last announced its earnings results on Wednesday, July 23rd. The company reported $0.57 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.50 by $0.07. The company had revenue of $448.00 million for the quarter, compared to the consensus estimate of $426.50 million. During the same quarter last year, the company posted $0.43 earnings per share. Illumina’s revenue was up 29.5% compared to the same quarter last year. On average, analysts predict that Illumina will post $2.29 earnings per share for the current fiscal year.

Illumina, Inc (NASDAQ:ILMN) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function.

Receive News & Ratings for Illumina Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Illumina Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.